| CAS NO: | 1420477-60-6 |
| 规格: | ≥98% |
| 包装 | 价格(元) |
| 1mg | 电议 |
| 2mg | 电议 |
| 5mg | 电议 |
| 10mg | 电议 |
| 25mg | 电议 |
Acalabrutinib D4 (ACP196 D4) is the tetra-deuterated form of Acalabrutinib (ACP-196; trade name: Calquence), which is a selective and second-generation BTK inhibitor approved in 2017 by FDA to treat adults with mantle cell lymphoma.
纯度：≥98%
CAS：1420477-60-6 (unlabeled)
m.cnreagent.com